Emory Cardiac Toolbox with Syntermed Live™

Unleash your productivity with cutting-edge nuclear cardiology...


Emory Cardiac Toolbox with Syntermed Live™

Unleash your productivity with cutting-edge nuclear cardiology software

The state of Nuclear Cardiology

The current world of Nuclear Cardiology is fast-paced, data-driven, and outcomes-based – making it more difficult than ever to stay up to date with the latest technology, software, and clinical and accreditation standards.

That’s why GE Healthcare has teamed up with Syntermed, Inc., to provide the Emory Cardiac Toolbox with Syntermed Live™
– Now available from GE Healthcare.

The latest tools and clinical applications to help improve your Nuclear Cardiology practice and workflow

The Emory Cardiac Toolbox with Syntermed Live™ provides anytime, anywhere remote reading and reporting from virtually any system. It’s simple to integrate and access, helping to quickly and easily maximize productivity, save time and help reduce errors – without the possible hassle or high price tag involved in upgrading or purchasing new imaging equipment. This solution is designed to help standardize and improve reporting (using the SmartReport™ tool), help increase workflow efficiency, enable greater diagnostic confidence (through the Image Decision Support™ tool) and drive speed in clinical decisions, ultimately leading to potentially improved patient outcomes and greater clinical capacity.

Let’s Talk

Ready to see where you can go with the Emory Cardiac Toolbox4? Contact your local Nuclear Pharmacy Sales Specialist to get the conversation started.

Optimized performance begins with the right tools Emory Cardiac Toolbox

  • upload

    Latest technology and applications with convenient remote accessibility

  • Helps maximize productivity and drive operational efficiencies

  • doctor

    Helps improve diagnostic confidence

  • calculator


System requirements

Microsoft® Windows® 7 SP1 Core i3/i5, 4GB RAM, and a 24" 1080p monitor
Microsoft Windows 10 (64 bit) Core i7, 8GB RAM, SSD, and a 24" 1920x1200 monitor
For more details on technical specifications, please visit: https://www.syntermed.com/system-requirements.

Indications for Use

The Emory Cardiac Toolbox should be used for the quantification of myocardial perfusion for the display of wall motion and quantification of left-ventricular function parameters from SPECT and PET myocardial perfusion studies for the 3D alignment of coronary artery models from CT coronary angiography onto the left ventricular 3D epicardial surface, for the assessment of cardiac mechanical dyssynchrony using phase analysis, for generation of the short axis, vertical, and horizontal long axis tomograms from the SPECT raw data using either filtered backprojection (FBP) or iterative reconstruction (MLEM/OSEM) for the quantification of myocardial blood flow and coronary flow reserve, and for the decision support in interpretation (LVX) and automatic structured reporting of the study. The product is intended for use by trained nuclear technicians and nuclear medicine or nuclear cardiology physicians. The clinician remains ultimately responsible for the final interpretation and diagnosis based on standard practices and visual interpretation of all SPECT and PET data.

PRODUCT INDICATIONS: Myoview™ 30 mL (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) is indicated for myocardial perfusion imaging under rest and/or exercise or pharmacologic stress conditions to delineate regions of reversible myocardial ischemia or infarcted myocardium in patients with known or suspected coronary artery disease. Myoview is also indicated for the assessment of left ventricular function (left ventricular ejection fraction and wall motion) in patients with known or suspected heart disease.
Important Risk and Safety Information About Myoview™ (Kit for the Preparation of Technetium Tc-99m Tetrofosmin for Injection) CONTRAINDICATIONS: None known. WARNINGS and PRECAUTIONS — Risks Associated With Exercise or Pharmacologic Stress: Patients evaluated with exercise or pharmacologic stress may experience serious adverse reactions such as myocardial infarction, arrhythmia, hypotension, and bronchoconstriction, as well as cerebrovascular reactions such as headache, paraesthesias, convulsions, somnolence and cerebrovascular accident, including hemorrhage. Perform stress testing in a setting where cardiac resuscitation equipment and trained staff are readily available. When pharmacologic stress is selected as an alternative to exercise, perform the procedure in accordance with the pharmacologic stress agent's prescribing information. Radiation Risks: Technetium Tc-99m contributes to a patient’s overall long-term cumulative radiation exposure. Long-term cumulative radiation exposure is associated with an increased risk of cancer. Ensure safe handling and preparation reconstitution procedures to protect patients and healthcare workers from unintentional radiation exposure. Encourage adequate hydration; instruct patients to void when the examination is completed and as often thereafter as possible. Hypersensitivity Reactions: Hypersensitivity reactions, including anaphylaxis, dyspnea, bronchospasm, throat tightness, coughing, tachycardia, chest pain, hypotension, abdominal pain, and cutaneous reactions (rash, urticuria, pruritus, erythema, and swelling or angiodema) have been observed after the administration of Myoview. Always have cardiopulmonary resuscitation equipment and personnel available, and monitor all patients for hypersensitivity reactions. Nursing Mothers: Technetium Tc-99m tetrofosmin is present in human milk in small amounts (<1% of maternal dose). There are no data available regarding the effects of technetium Tc-99m tetrofosmin on the breastfed infant or on milk production. The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for Myoview and any other potential adverse effects on the breastfed child from Myoview or from the underlying maternal condition. Pediatric Use: Safety and effectiveness in pediatric patients have not been established. Geriatric Use: No overall differences in safety were observed between these subjects and younger subjects. Other reported clinical experience has not identified differences in responses between elderly and younger patients, but greater sensitivity regarding some older individuals cannot be ruled out. ADVERSE REACTIONS: Serious episodes of angina, ventricular tachycardia, and respiratory arrest were reported. Other events included angina, hypertension, torsades de pointes, vomiting, abdominal discomfort, cutaneous allergy, hypotension, dyspnea, metallic taste, burning of the mouth, and smell alteration. The following were reported when used with pharmacological stress: Angina, flushing, dyspnea, headache, abdominal pain, dizziness, palpitations, nausea, hypotension, pain, cough, arrhythmia, bronchospasm, ECG (electrocardiogram) abnormalities, hypertension, vomiting, and asthenia. Postmarketing adverse reactions included rash, urticaria, abnormal vision, hypersensitivity reactions, and fever.
Prior to Myoview administration, please read the full Prescribing Information.

To report SUSPECTED ADVERSE REACTIONS, contact GE Healthcare at 800 654 0118 (option 2), or the FDA at 800 FDA 1088 or www.fda.gov/medwatch
References: 1. AuntMinnie.com website. Survey finds U.S. installed base of gamma cameras is aging. https://www.auntminnie.com/index.aspx?sec=ser&sub=def&pag=dis&ItemID=103797. Accessed January 15, 2018. 2. Lin et al. Repeatability of left ventricular dysynchrony and function parameters in serial gated myocardial perfusion SPECT studies. J Nucl Cardio. 2010;17:811-6. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2992839/. Accessed January 15, 2018. 3. Russell Folks, et al. JNM. May 2014. 4. 510(k) clearance summary for Emory Cardiac Toolbox 4.0. FDA website.
https://www.accessdata.fda.gov/cdrh_docs/pdf12/K123646.pdf. Accessed on April 24, 2018.
© 2018 General Electric Company.
GE, the GE Monogram, and Myoview are trademarks of General Electric Company.
Emory Cardiac Toolbox and Syntermed IDS are trademarks of Syntermed Inc.All other third party trademarks are property of their respective owners.